JPWO2019153009A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019153009A5 JPWO2019153009A5 JP2020564045A JP2020564045A JPWO2019153009A5 JP WO2019153009 A5 JPWO2019153009 A5 JP WO2019153009A5 JP 2020564045 A JP2020564045 A JP 2020564045A JP 2020564045 A JP2020564045 A JP 2020564045A JP WO2019153009 A5 JPWO2019153009 A5 JP WO2019153009A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- acid sequence
- regulatory element
- segment
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000007523 nucleic acids Chemical class 0.000 claims description 310
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 173
- 108020004707 nucleic acids Proteins 0.000 claims description 137
- 102000039446 nucleic acids Human genes 0.000 claims description 137
- 230000001105 regulatory effect Effects 0.000 claims description 122
- 239000013598 vector Substances 0.000 claims description 36
- 108700019146 Transgenes Proteins 0.000 claims description 18
- 239000003623 enhancer Substances 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 15
- 210000004027 cell Anatomy 0.000 claims description 14
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 8
- 102100036912 Desmin Human genes 0.000 claims description 4
- 108010044052 Desmin Proteins 0.000 claims description 4
- 102100033448 Lysosomal alpha-glucosidase Human genes 0.000 claims description 4
- 102000001435 Synapsin Human genes 0.000 claims description 4
- 108050009621 Synapsin Proteins 0.000 claims description 4
- 241000700605 Viruses Species 0.000 claims description 4
- 210000005045 desmin Anatomy 0.000 claims description 4
- 210000001808 exosome Anatomy 0.000 claims description 4
- 239000013646 rAAV2 vector Substances 0.000 claims description 4
- 239000013603 viral vector Substances 0.000 claims description 4
- 241001655883 Adeno-associated virus - 1 Species 0.000 claims description 2
- 241000702423 Adeno-associated virus - 2 Species 0.000 claims description 2
- 241000202702 Adeno-associated virus - 3 Species 0.000 claims description 2
- 241000580270 Adeno-associated virus - 4 Species 0.000 claims description 2
- 241001634120 Adeno-associated virus - 5 Species 0.000 claims description 2
- 241000972680 Adeno-associated virus - 6 Species 0.000 claims description 2
- 241001164823 Adeno-associated virus - 7 Species 0.000 claims description 2
- 241001164825 Adeno-associated virus - 8 Species 0.000 claims description 2
- 102100029470 Apolipoprotein E Human genes 0.000 claims description 2
- 101710095339 Apolipoprotein E Proteins 0.000 claims description 2
- 241000702421 Dependoparvovirus Species 0.000 claims description 2
- 208000032007 Glycogen storage disease due to acid maltase deficiency Diseases 0.000 claims description 2
- 206010053185 Glycogen storage disease type II Diseases 0.000 claims description 2
- 241000713666 Lentivirus Species 0.000 claims description 2
- 241000700618 Vaccinia virus Species 0.000 claims description 2
- 230000002378 acidificating effect Effects 0.000 claims description 2
- 108010028144 alpha-Glucosidases Proteins 0.000 claims description 2
- 239000000412 dendrimer Substances 0.000 claims description 2
- 229920000736 dendritic polymer Polymers 0.000 claims description 2
- 201000004502 glycogen storage disease II Diseases 0.000 claims description 2
- 210000003494 hepatocyte Anatomy 0.000 claims description 2
- 239000002502 liposome Substances 0.000 claims description 2
- 210000004185 liver Anatomy 0.000 claims description 2
- 210000000663 muscle cell Anatomy 0.000 claims description 2
- 239000002105 nanoparticle Substances 0.000 claims description 2
- 210000002569 neuron Anatomy 0.000 claims description 2
- 238000013518 transcription Methods 0.000 claims description 2
- 230000035897 transcription Effects 0.000 claims description 2
- 241000701161 unidentified adenovirus Species 0.000 claims description 2
- 241000701447 unidentified baculovirus Species 0.000 claims description 2
- 241001529453 unidentified herpesvirus Species 0.000 claims description 2
- 241001430294 unidentified retrovirus Species 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2023188066A JP2024012479A (ja) | 2018-02-05 | 2023-11-02 | 転写調節要素及びその使用 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862626561P | 2018-02-05 | 2018-02-05 | |
US62/626,561 | 2018-02-05 | ||
PCT/US2019/016692 WO2019153009A1 (en) | 2018-02-05 | 2019-02-05 | Transcription regulatory elements and uses thereof |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2023188066A Division JP2024012479A (ja) | 2018-02-05 | 2023-11-02 | 転写調節要素及びその使用 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2021512649A JP2021512649A (ja) | 2021-05-20 |
JPWO2019153009A5 true JPWO2019153009A5 (ru) | 2022-02-09 |
JP7381494B2 JP7381494B2 (ja) | 2023-11-15 |
Family
ID=67478520
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020564045A Active JP7381494B2 (ja) | 2018-02-05 | 2019-02-05 | 転写調節要素及びその使用 |
JP2023188066A Pending JP2024012479A (ja) | 2018-02-05 | 2023-11-02 | 転写調節要素及びその使用 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2023188066A Pending JP2024012479A (ja) | 2018-02-05 | 2023-11-02 | 転写調節要素及びその使用 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20210162073A1 (ru) |
EP (1) | EP3749756A4 (ru) |
JP (2) | JP7381494B2 (ru) |
CN (1) | CN111936621A (ru) |
MA (1) | MA51753A (ru) |
WO (1) | WO2019153009A1 (ru) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ760232A (en) | 2017-06-07 | 2023-05-26 | Regeneron Pharma | Compositions and methods for internalizing enzymes |
CN111902539A (zh) * | 2018-02-07 | 2020-11-06 | 吉尼松公司 | 杂合调控元件 |
US10842885B2 (en) | 2018-08-20 | 2020-11-24 | Ucl Business Ltd | Factor IX encoding nucleotides |
WO2021102107A1 (en) * | 2019-11-19 | 2021-05-27 | Asklepios Biopharmaceutical, Inc. | Therapeutic adeno-associated virus comprising liver-specific promoters for treating pompe disease and lysosomal disorders |
EP4107259A1 (en) * | 2020-02-18 | 2022-12-28 | Vrije Universiteit Brussel | Novel combination of nucleic acid regulatory elements and methods and uses thereof |
AR126660A1 (es) * | 2021-07-28 | 2023-11-01 | Univ Brussel Vrije | Mejorando la eficacia de la terapia génica dirigida a músculos |
WO2023173078A2 (en) * | 2022-03-11 | 2023-09-14 | Homology Medicines, Inc. | Bidirectional dual promoter expression vectors and uses thereof |
TW202409290A (zh) * | 2022-06-27 | 2024-03-01 | 美商安斯泰來基因治療股份有限公司 | 用於治療肌強直性營養不良之組合物及方法 |
WO2024074143A1 (en) * | 2022-10-08 | 2024-04-11 | Lingyi Biotech Co., Ltd. | Construct for enhancing gene expression |
CN118064436B (zh) * | 2024-04-18 | 2024-07-26 | 上海凌医生物科技有限公司 | 一种增强基因表达的嵌合启动子 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1390490B1 (en) * | 2001-05-24 | 2009-04-15 | Genzyme Corporation | Muscle-specific expression vectors |
US8021875B2 (en) * | 2001-08-27 | 2011-09-20 | Roche Madison Inc. | Methods for expression of transgenes |
US20070161031A1 (en) * | 2005-12-16 | 2007-07-12 | The Board Of Trustees Of The Leland Stanford Junior University | Functional arrays for high throughput characterization of gene expression regulatory elements |
AU2013277215A1 (en) * | 2012-06-19 | 2015-02-05 | University Of Florida Research Foundation, Inc. | Compositions and methods for treating diseases |
PL3097197T3 (pl) * | 2014-01-21 | 2021-06-28 | Vrije Universiteit Brussel | Mięśniowo-specyficzne elementy regulatorowe kwasów nukleinowych oraz sposoby i ich zastosowanie |
WO2015196179A1 (en) * | 2014-06-20 | 2015-12-23 | University Of Florida Research Foundation, Inc. | Methods of packaging multiple adeno-associated virus vectors |
WO2016172155A1 (en) * | 2015-04-23 | 2016-10-27 | University Of Massachusetts | Modulation of aav vector transgene expression |
-
2019
- 2019-02-05 MA MA051753A patent/MA51753A/fr unknown
- 2019-02-05 US US16/966,521 patent/US20210162073A1/en active Pending
- 2019-02-05 JP JP2020564045A patent/JP7381494B2/ja active Active
- 2019-02-05 CN CN201980015960.6A patent/CN111936621A/zh active Pending
- 2019-02-05 WO PCT/US2019/016692 patent/WO2019153009A1/en unknown
- 2019-02-05 EP EP19748361.3A patent/EP3749756A4/en active Pending
-
2023
- 2023-11-02 JP JP2023188066A patent/JP2024012479A/ja active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2018116076A (ru) | Модифицированные гены атаксии фридрейха и векторы для генной терапии | |
JP2020522269A5 (ru) | ||
JP2021106619A5 (ru) | ||
JP2021019591A5 (ru) | ||
JP2022068181A5 (ru) | ||
JP2020533959A5 (ru) | ||
JP2018531609A5 (ru) | ||
TW201704253A (zh) | 殼體 | |
JP2007507223A5 (ru) | ||
JPWO2019153009A5 (ru) | ||
JP2017529395A5 (ru) | ||
JP2020509786A5 (ru) | ||
JP7541027B2 (ja) | 筋肉発現のためのハイブリッドプロモーター | |
JPWO2020106916A5 (ru) | ||
JPWO2021077000A5 (ru) | ||
JPWO2019152609A5 (ru) | ||
JPWO2021053222A5 (ru) | ||
FI3177313T3 (fi) | Telomeraasi-käänteistranskriptaasipohjaisia hoitoja sydäninfarktiin liittyvien tilojen hoitamiseksi | |
JP2020533313A5 (ru) | ||
JPWO2019210181A5 (ru) | ||
JPWO2021014428A5 (ru) | ||
AR129014A1 (es) | Composiciones y métodos para el tratamiento de distrofias musculares | |
JPWO2021076911A5 (ru) | ||
JPWO2020214609A5 (ru) | ||
JPWO2020232297A5 (ru) |